GPT-Rosalind-6 offered as research model for biology
The addendum describes the new gpt-rosalind-6 model, a frontier reasoning model for biology, drug discovery, and translational medicine. It is offered as gpt-rosalind-6 research to qualified scientists, research institutes, companies and government partners. The model uses the same weights as gpt-6 astra, the flagship reasoning model. It has fewer refusals on dual‑use biological queries but is…
Key points
- gpt-rosalind-6 is a frontier reasoning model for biology, drug discovery, and translational medicine
- it is offered as research model to qualified scientists, institutes, companies and government partners
- the model uses same weights as gpt-6 astra and has fewer refusals on dual-use biological queries
The addendum outlines safety and alignment evaluations, deployment safeguards, and the model’s biological capability assessment. The Preparedness Framework classifies the launch as high capability in the biological and chemical domain, below the threshold for critical. Gpt‑rosalind‑6 is treated as critical in cybersecurity and below high in AI self‑improvement. The addendum also includes results for gpt‑rosalind‑5.5 for comparison and should be read alongside the gpt‑6 astra system card.
Model page: GPT-6 Astra →
GPT-Rosalind-6 System Card Addendum
deploymentsafety.openai.com · 30 October 2026
Loading the full article…
This text was published by deploymentsafety.openai.com. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
Coverage and discussion
1source- Hacker News discussion · 43 pointsnews.ycombinator.com
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Research
All →- Researchers demonstrate pretraining poisoning backdoors in Qwen3 agents · 1 src
- Researchers introduce PathLUPI to improve molecular prediction from histology images · 1 src
- MIT researchers win 2026 Pritzker Prize for AI antibiotic work · 1 src
- Empero Research releases PiVo-1.4M, a 1.4M-parameter text-to-speech model for local use · 1 src
- Unite.AI explains AI latency and throughput metrics for engineers · 1 src
Comments
via GitHub Discussions